Home
Conditions
Bioequivalence Study in Healthy Subjects

Clinical trial condition

Bioequivalence Study in Healthy Subjects

Explore clinical trials studying Bioequivalence Study in Healthy Subjects. Study availability and eligibility vary by location and protocol.

14 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Bioequivalence Study in Healthy Subjects trial results

Not yet recruiting

Bioequivalence of Two Formulations of Parecoxib in Healthy Volunteers Under Fasting Conditions

NCT06600282

Conditions: Bioequivalence Study in Healthy Subjects, Neurologic Manifestations, Pain, +6 more
Locations: Taichung Veterans General Hospital Taichung, Taiwan

View Trial Details

Active, not recruiting

Bioequivalence Study of SKI-O-703 in Healthy Adults Under Fed Conditions

NCT07675226

Conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +25 more
Locations: Oscotec Seongnam-si, Gyeonggi-do, South Korea

View Trial Details

Completed

Brivaracetam Bioequivalence Assessment

NCT07800533

Conditions: Bioequivalence Study in Healthy Subjects
Locations: Unidade Integrada de Farmacologia e Gastroenterologia (UNIFAG) Bragança Paulista, São Paulo, Brazil

View Trial Details

Completed

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 850 mg Tablets Under Fed Conditions.

NCT07633028

Conditions: Bioequivalence Study in Healthy Subjects
Locations: Axis Clinicals Latina, S.A. de C.V. Mexico City, Mexico

View Trial Details

Completed

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 500 mg Tablets Under Fed Conditions.

NCT07633054

Conditions: Bioequivalence Study in Healthy Subjects
Locations: Axis Clinicals Latina, S.A. de C.V. Mexico City, Mexico

View Trial Details

Completed

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 12.5 mg / 1000 mg Tablets Under Fed Conditions.

NCT07633041

Conditions: Bioequivalence Study in Healthy Subjects
Locations: Axis Clinicals Latina, S.A. de C.V. Mexico City, Mexico

View Trial Details

Completed

Clinical Study to Determine Bioequivalence Between Two Oral Medications of Empagliflozin/Metformin in 5 mg / 850 mg Tablets Under Fed Conditions.

NCT07633015

Conditions: Bioequivalence Study in Healthy Subjects
Locations: Axis Clinicals Latina, S.A. de C.V. Mexico City, Mexico

View Trial Details

Completed

Rivastigmine Transdermal Patches Bioequivalence and Adhesion Assessment

NCT07464340

Conditions: Bioequivalence Study in Healthy Subjects
Locations: Instituto de Ciências Farmacêuticas de Estudos e Pesquisas Aparecida de Goiânia, Goiás, Brazil

View Trial Details

Completed

Bioavailability and Bioequivalence Study of ER Torsemide and Spironolactone FDC Tablet in Healthy Subjects

NCT07015671

Conditions: Bioequivalence Study in Healthy Subjects, PK/PD
Locations: Sarfez Pharmaceuticals Vienna, Virginia, United States

View Trial Details

Completed

Bioequivalence Assessment Between Two Imeglimin Hydrochloride Film Coated Tablet Formulations

NCT07127094

Conditions: Bioequivalence Study in Healthy Subjects, Diabetes Mellitus, Endocrine System Diseases, +3 more
Locations: Advanced Research Center (ARC) Cairo, Egypt

View Trial Details

Bioequivalence Study in Healthy Subjects

Bioequivalence Study in Healthy Subjects trial results

Related conditions